Following the concept of precision medicine, assessing Plin2 levels will allow for the stratification of tumor responsiveness to specific mitosis‐targeting drugs, including future Trip13 inhibitors as well as clinically established drugs such as paclitaxel. This evidence concerns the gene PLIN2 and neoplasm.